Skip to main content

Odyssey Group International Inc. (ODYY)

OTCMKTS: ODYY · IEX Real-Time Price · USD
0.3087 -0.0123 (-3.83%)
Oct 20, 2021 2:03 PM EDT - Market closed
Market Cap24.57M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out82.72M
EPS (ttm)-0.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,574
Open0.3022
Previous Close0.3210
Day's Range0.2901 - 0.3246
52-Week Range0.1050 - 2.0000
Beta1.49
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About ODYY

Odyssey Group International, Inc. focuses on development, acquisition, and commercialization of medical products and health related technologies. It intends to offer medical devices. The company has development projects in three technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat rare brain disorders. Odyssey Group International, Inc. was founded in 2014 and is based in Irvine, California.

IndustryMedical Devices
Founded2014
Employees1
Stock ExchangeOTCMKTS
Ticker SymbolODYY
Full Company Profile

Financial Performance

Financial Statements

News

Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device

IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) --   Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving medical ...

6 days ago - GlobeNewsWire

Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion

IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical products, ...

1 month ago - GlobeNewsWire

Odyssey Group International Approved to Start Human Trial to Treat Concussion

IRVINE, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today an...

1 month ago - GlobeNewsWire

Odyssey Group International Completes IND-enabling Studies, Submits Investigator's Brochure for Phase 1 Clinical Trial

IRVINE, CA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-s...

2 months ago - GlobeNewsWire

Odyssey Group International, Inc. Provides Notice of Annual Meeting of Stockholders

IRVINE, CA, July 26, 2021 (GLOBE NEWSWIRE) --  Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a t...

2 months ago - GlobeNewsWire

Odyssey Group International Reports Achieving Drug Safety Standards for Clinical Trials of its Drug for Treating Conc...

IRVINE, CA, June 29, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life...

3 months ago - GlobeNewsWire

Odyssey Group International to Present at LD Micro Virtual Investor Conference

IRVINE, CA, June 08, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:  ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, lif...

4 months ago - GlobeNewsWire

Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treatin...

Irvine, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life...

4 months ago - GlobeNewsWire

Odyssey Group International Announces Successful Toxicology Studies for its Concussion Drug

Enters Agreement with Contract Research Organization for Phase 1 Trial Enters Agreement with Contract Research Organization for Phase 1 Trial

4 months ago - GlobeNewsWire

Odyssey Group International, Inc. Schedules Annual Meeting of Stockholders

IRVINE, CA, May 24, 2021 (GLOBE NEWSWIRE) -- – Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a t...

5 months ago - GlobeNewsWire

Odyssey Group International Welcomes Global Operations and Quality Leader Ricky Richardson to Board of Directors

IRVINE, CA, May 13, 2021 (GLOBE NEWSWIRE) --  Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"),a technology and asset acquisition company focused on developing unique, life-...

5 months ago - GlobeNewsWire

Odyssey Group International Announces Formation of Scientific Advisory Board

Irvine, CA, April 14, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, lif...

6 months ago - GlobeNewsWire

Odyssey Group International to Present at Virtual Investor Summit on March 24, 2021 at 2:30 PM ET

CEO Michael Redmond to Highlight the Company's Strategy in Developing and Acquiring Life-Saving Medical Products IRVINE, CA / ACCESSWIRE / March 22, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY)...

7 months ago - Accesswire

Odyssey Group International Announces Formation of Sports Advisory Board to Enhance Awareness of Traumatic Brain Inju...

Inaugural members of the Sports Advisory Board (SAB) include Kurt Warner, Brett Favre, Mark Rypien, David Ross and Steve “Mooch” Mariucci Inaugural members of the Sports Advisory Board (SAB) include Kur...

7 months ago - GlobeNewsWire

Odyssey Group International Announces Upcoming Television Appearance by Brett Favre and Dr. Jake VanLandingham on New...

IRVINE, CA / ACCESSWIRE / March 10, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-savi...

7 months ago - Accesswire

Odyssey Group International, Inc. Closes Acquisition of Novel Concussion Drug

Anticipates initiation of Phase 1 clinical trials of PRV-002 during the Second Quarter of 2021 IRVINE, CA / ACCESSWIRE / March 2, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) ("Odyssey"), a tec...

7 months ago - Accesswire

Odyssey Group International to Acquire Concussion Drug Asset from Prevacus, Inc.

All Stock Transaction Phase 1 Clinical Trial Site, Protocol and CRO Established IRVINE, CA / ACCESSWIRE / January 11, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) (the “Company” or “Odyssey”), ...

9 months ago - Accesswire